The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study.

MLA

Morice, Alyn H., et al. “The Effect of Gefapixant, a P2X3 Antagonist, on Cough Reflex Sensitivity: A Randomised Placebo-Controlled Study.” The European Respiratory Journal, vol. 54, no. 1, July 2019. EBSCOhost, https://doi.org/10.1183/13993003.00439-2019.

APA

Morice, A. H., Kitt, M. M., Ford, A. P., Tershakovec, A. M., Wu, W.-C., Brindle, K., Thompson, R., Thackray-Nocera, S., & Wright, C. (2019). The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study. The European Respiratory Journal, 54(1). https://doi.org/10.1183/13993003.00439-2019

Chicago

Morice, Alyn H, Michael M Kitt, Anthony P Ford, Andrew M Tershakovec, Wen-Chi Wu, Kayleigh Brindle, Rachel Thompson, Susannah Thackray-Nocera, and Caroline Wright. 2019. “The Effect of Gefapixant, a P2X3 Antagonist, on Cough Reflex Sensitivity: A Randomised Placebo-Controlled Study.” The European Respiratory Journal 54 (1). doi:10.1183/13993003.00439-2019.